David Lowenschuss has over 25 years of experience working in the biotech and life science industry. He has worked in a number of different roles at large and small pharmaceutical and biotech companies, including Pfizer Inc. and Esperion Therapeutics, Inc where he was involved in a number of licensing and M/A transactions. Mr. Lowenschuss is a Board Member of Mekanistic Therapeutics LLC a start-up oncology company. Mr. Lowenschuss also co-founded and served as a founding board member of Gemphire Therapeutics, Inc. (NASDAQ: GEMP). Mr. Lowenschuss also co-founded Michigan Life Ventures, LLC. He holds a J.D. from George Washington University and an M.U.P. and B.A. from the University of Michigan.